logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

China Railway (00390) announced on October 23 that it will spend 1999.95 million yuan to repurchase 3.4911 million A-shares.

date
13:29 24/10/2025
avatar
GMT Eight
China Railway Group (00390) announced that on October 23, 2025, the company will invest 1999.95 million...
China Railway (00390) announced that on October 23, 2025, the company spent 1999.95 million yuan to repurchase 3.4911 million A-shares, with a repurchase price of 5.69-5.75 yuan per share.
Related Articles
HK Stock Market Move | MMG(01208) closing price rose more than 7%, operations at the Las Bambas mine area are stable, institutions raise full-year copper production guidance.
China Stock
Tonghua Dongbao Pharmaceutical (600867.SH): Recombinant Human Insulin Injection receives foreign drug registration certificate.
China Stock
Beijing Foyou Pharma (601089.SH) has obtained the approval notice for the listing application of the raw material kelevoron.
HK Stock Market Move | MMG(01208) closing price rose more than 7%, operations at the Las Bambas mine area are stable, institutions raise full-year copper production guidance.
Tonghua Dongbao Pharmaceutical (600867.SH): Recombinant Human Insulin Injection receives foreign drug registration certificate.
China Stock
Beijing Foyou Pharma (601089.SH) has obtained the approval notice for the listing application of the raw material kelevoron.
China Stock
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
Why European Automakers Are Opposing Dutch Sanctions
icon
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
icon
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
icon
20/10/2025
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.